Altium Capital

Chemomab Therapeutics is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet need that involve Inflammation and fibrosis

• EGenesis At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure

At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure

• Gemini Therapeutics Gemini Therapeutics is a precision medicine company focused on the development of new therapies for dry AMD

Gemini Therapeutics is a precision medicine company focused on the development of new therapies for dry AMD

• Hummingbird Bioscience We are a clinical-stage biotechnology company with a proprietary and differentiated Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease

We are a clinical-stage biotechnology company with a proprietary and differentiated Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease

• Hyperfine At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe

At Hyperfine, Rothberg and his team of scientists and engineers set out to put MR imaging within reach of every patient regardless of location—in any healthcare facility in any country across the globe

• Immunovant Immunovant, Inc
• is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases

Immunovant, Inc is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases

• Ocuphire Pharma Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders

• Palisade Bio Palisade Bio is a late-stage biopharma company advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage

Palisade Bio is a late-stage biopharma company advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage

• Quoin Quoin is an emerging specialty pharmaceutical company dedicated to developing therapeutic products for the treatment of rare and orphan diseases for which no FDA-approved treatments currently exist

Quoin is an emerging specialty pharmaceutical company dedicated to developing therapeutic products for the treatment of rare and orphan diseases for which no FDA-approved treatments currently exist

• Sagimet Biosciences A clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers

A clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers

• Seelos Therapeutics Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications Seelos intends to become a leading biopharmaceutical company focused on neurological and psychiatric disorders, including orphan indications
• Sonnet BioTherapeutics At Sonnet BioTherapeutics, we are taking the fight directly to cancer

At Sonnet BioTherapeutics, we are taking the fight directly to cancer

• Timber Pharmaceuticals Timber was formed around the collaboration of three companies with demonstrated experience in all phases of drug development and clinical research

Timber was formed around the collaboration of three companies with demonstrated experience in all phases of drug development and clinical research

• Vincerx Pharma Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer

Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer

• Yumanity Therapeutics Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform

Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform